Thursday, May 19th, 2016

About the Postmenopausal Osteoporosis Drugs Market 

Bones have the ability to grow and heal naturally, but changes in diet, exercise levels, and body chemistry lead to changes in the bone mineral density. This results in osteoporosis, which is characterized by low bone density and structural deterioration of bone tissues, leading to fragile bones. Rapid bone resorption or slow bone replacement can result in the development of the disease. Gender, age, body size (low body weight), ethnicity, and family history also play a role in developing osteoporosis. Other risk factors include medication, calcium and vitamin intake, alcohol intake, and smoking. 
Women are at a greater risk of developing osteoporosis than men as estrogens play an important role in maintaining bone strength. Small amounts of bone are lost as part of normal aging process, but on reaching menopause, estrogen levels decline drastically, leading to a greater risk of developing osteoporosis. 

Technavio’s analysts forecast the Global Postmenopausal Osteoporosis Drugs Market to grow at a CAGR of 4.02% during the period 2016-2020. 

Complete report details @                   

Covered in this report 
The report covers the present scenario and the growth prospects of the Global Postmenopausal Osteoporosis Drugs Market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded and generic drugs used to treat and prevent postmenopausal osteoporosis.

The market is divided into the following segments based on geography: 
• Americas 

Technavio's report, Global Postmenopausal Osteoporosis Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. 

Request a sample report @         

Key vendors 
• Eli Lilly 
• Amgen 
• Merck 
• Novartis

Other prominent vendors 
• Allergan 
• Amgen Astellas Biopharm 
• Deltanoid Pharmaceuticals 
• Noven 
• Novo Nordisk 
• Osteologix 
• Pfizer 
• PhytoHealth 
• Radius Health 
• Tarsa Therapeutics 
• UCB 
• Uni-Bio Science Group 
• Upsher-Smith Laboratories 
• Watson Pharmaceuticals 
• Zosano Pharma 

Market driver 
• Growing prevalence of postmenopausal osteoporosis 
• For a full, detailed list, view our report 

Market challenge 
• Low diagnosis rate 
• For a full, detailed list, view our report 

Market trend 
• Emergence of novel agents 
• For a full, detailed list, view our report 

Key questions answered in this report 
• What will the market size be in 2020 and what will the growth rate be? 
• What are the key market trends? 
• What is driving this market? 
• What are the challenges to market growth? 
• Who are the key vendors in this market space? 
• What are the market opportunities and threats faced by the key vendors? 
• What are the strengths and weaknesses of the key vendors? 

Make an enquiry before buying this Report @     



PART 01: Executive summary 
• Highlights 
PART 02: Scope of the report 
• Market overview 
• Top-vendor offerings 
PART 03: Market research methodology 
• Research methodology 
• Economic indicators 
PART 04: Introduction 
• Key market highlights 
PART 05: Disease overview 
• Understanding postmenopausal osteoporosis 
• Epidemiology and demography 
• Risk factors 
• Symptoms 
• Diagnosis 
• Treatment 
PART 06: Key buying criteria 
PART 07: Pipeline scenario 

• Romosozumab (AMG785) 
• Odanacatib (MK-0822) 
• Abaloparatide SC/Abaloparatide transdermal patch 
• PHN-031 (PH3) 
• NB S101 
• Teriparatide ZP Patch (ZP-PTH) 
• Blosozumab (LY2541546) 
PART 08: Market landscape 
• Market overview 
• Market size and forecast 
• Five forces analysis 
PART 09: Market segmentation by therapeutic class 
• Antiresorptive medications 
• Anabolic medications 
PART 10: Market segmentation by line of therapy 
PART 11: Geographical segmentation 

• Global postmenopausal osteoporosis drugs market by geographical segmentation 2015-2020 
• Postmenopausal osteoporosis drugs market in Americas 
• Postmenopausal osteoporosis drugs market in EMEA 
• Postmenopausal osteoporosis drugs market in APAC 
PART 12: Market drivers 
• Increase in older population 
• Growing prevalence of postmenopausal osteoporosis 
• Expected launch of promising pipeline molecules 
• High unmet medical needs 
PART 13: Impact of drivers 
PART 14: Market challenges 

• Multiple patent expiries 
• Low diagnosis rate 
• Nonadherence to treatment regimen 
• Drug reimbursement issues 
PART 15: Impact of drivers and challenges 
PART 16: Market trends 

• Awareness programs and initiatives 
• Emergence of novel agents 
• Emergence of combination therapies 
PART 17: Vendor landscape 
• Competitive scenario 
• Market analysis 2015 
• Eli Lilly 
• Amgen 
• Merck 
• Novartis 
• Other prominent vendors 
PART 18: Appendix 
• List of abbreviations 
PART 19: Explore Technavio 

Buy this report @


Contact US:


Partner Relations & Marketing Manager

[email protected]

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)          


Contact Profile


Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Our Market Research Reports and Consulting Services 

Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories. The Wise Guy Reports team prides itself in being the chosen source for market research reports, report customizations services, and other ancillary services such as a Newsletter service and corporate service for large organizations.

Hundreds of large and small organizations across virtually every industry sector worldwide are currently reaping rich dividends from the sharp insights provided by market research reports sourced through Wise Guy Reports. 

Gaining an insight into emerging trends, opportunities and potential threats is key to long-term sustenance in a competitive environment. The handpicked collection of market research reports on Wise Guy Reports is centred on this proven principle.

Norah Trent
P: +44 208 133 9349
M: +1 646 845 9349


Postmenopausal Osteoporosis Drugs market trend, Postmenopausal Osteoporosis Drugs market segmentation, Postmenopausal Osteoporosis Drugs market analysis, Postmenopausal Osteoporosis Drugs market parameters, Postmenopausal Osteoporosis Drugs industry




More Formats

View QR Code